Dr. Jehad Almaliti at UC San Diego Scripps Oceanography has received an extended St. Baldrick’s grant to develop a drug that can cross the blood-brain barrier to treat pediatric brain tumors. His team has a promising candidate in preclinical testing. Retweet to share the news!

March is only 3 months away! Now’s the time to register your own head-shaving event and rally your community to fight childhood cancer. Every event brings hope! 👉 Register (or re-register) your event here: https://t.co/Cy277gBIS7

Waylon is only 3 years old, but he’s already fighting a brain tumor with courage that inspires everyone around him. ❤️ ➡️ Read his story and learn how research helps kids like him: https://t.co/Bm5K0K3kYZ

The holidays shine brighter when kids like Annie get more time to be kids. ⛄ A new treatment dispensed through a backpack makes that possible. Fuel more lifesaving research by taking on the 28-day backpack challenge: https://t.co/y01IWZfriX #SendKidsCancerPacking

Lilah is 2 years old. Spunky. Brave. Facing ATRT, a rare pediatric brain cancer w/ a current 5-year survival rate of about 40%. 💔 She keeps shining despite chemo, stem cell rescue, & countless hospital days. Cures can’t wait. Futures await. Give now: https://t.co/wgKxLn0Vab

We hosted another successful Brave A Shave fundraiser for @StBaldricks foundation led by our @wildcatsenate on Friday!

Cancer interrupted Juanita’s childhood, but her life was redirected toward purpose. ❤️ For Juanita, learn how gold can be found in the toughest of battles: https://t.co/ZGMPw0fIEq

Cancer interrupted Juanita’s childhood, but her life was redirected toward purpose. ❤️ For Juanita, learn how gold can be found in the toughest of battles: https://t.co/ZGMPw0fIEq

Upstate has received a $50K @StBaldricks Infrastructure Grant to support expanded pediatric cancer clinical trials and improve access to advanced care for children in our region. Read more: https://t.co/kYvkoSjhk0

Lynne has shaved her head in solidarity w/ kids fighting cancer for nearly 20 years. This year, she joined the #SendKidsCancerPacking challenge: 28 days, 28 kids honored, 1 mission—fund research that saves lives. Take your own backpack on a 28-day quest: https://t.co/VUkoSSa9Qa

Thanks to a $200k St. Baldrick’s Research Grant, Dr. Jianping Huang at the University of Florida launched a promising new CAR T-cell therapy for kids with aggressive and deadly pediatric brain tumors. 🧠 Research gives kids a fighting chance. 💚 Like and retweet to spread hope.

The bright green backpacks are everywhere & they’re sparking conversations. Inspired by a breakthrough in leukemia treatment, the backpack challenge makes kids' cancer research visible in a powerful way. 💚 Wear the backpack & #SendKidsCancerPacking: https://t.co/5jTPOenINf

Eric’s 4th annual St. Baldrick’s workout at CrossFit Endemic was the biggest yet — complete with three workouts, community support, a special survivor-honoring workout, and shavees like Eric. This is what hope in action looks like. 💛 Like and retweet to spread hope!

💛 Thank you for giving kids with cancer the futures they deserve. Every gift moves us closer to brighter tomorrows!

That’s enough to fund a one-year research grant — giving scientists the tools to test bold ideas, create safer treatments, and bring new therapies closer to kids who need them most.

With an extra $20,000 pledge and employer matches still being counted, the total impact is now over $120,000! 🎉

Because of you, the full $25,000 match from the Cetina-Chiu Family was unlocked — and donations went far beyond expectations!

💛 Thank you for showing up for kids with cancer this Giving Tuesday! Your support has been incredible.

Her team will study a promising treatment using T3 alongside chemotherapy. T3 is an active thyroid hormone that has anti-tumor effects in medulloblastoma models. Research brings hope — especially when options are few. 💛 Like and retweet to raise awareness.

Thanks to a $330k St. Baldrick’s Scholar Grant, supported by Hannah's Heroes Hero Fund, Dr. Rebecca Ronsley at Seattle Children’s is leading a new clinical trial for relapsed medulloblastoma, the most common malignant brain tumor in kids.